Skip to main content
SpringerLink
Log in

Pathology of Lung Cancer

  • Chapter
  • First Online:
Airway diseases

  • 673 Accesses

Abstract

Lung carcinomas are the most common type of carcinomas and the leading cause of cancer death worldwide regardless of gender [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Inamura K. Lung cancer: understanding its molecular pathology and the 2015 who classification. Front Oncol. 2017;28(7):193. https://doi.org/10.3389/fonc.2017.00193.

    Article  Google Scholar 

  2. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG, editors. World Health Organization classification of tumours of the lung, pleura, thymus and heart. Lyon: IARC; 2015.

    Google Scholar 

  3. Whithaus K, Fukuoka J, Prihoda TJ, et al. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Arch Pathol Lab Med. 2012;136(2):155–62. https://doi.org/10.5858/arpa.2011-0232-OA.

    Article  PubMed  Google Scholar 

  4. Osmani L, Askin F, Gabrielson E, et al. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy. Semin Cancer Biol. 2018;52:103–9. https://doi.org/10.1016/j.semcancer.2017.11.019.

    Article  CAS  PubMed  Google Scholar 

  5. Travis WD. lung cancer pathology: Current concepts. Clin Chest Med. 2020;41(1):67–85. https://doi.org/10.1016/j.ccm.2019.11.001.

    Article  PubMed  Google Scholar 

  6. Yatabe Y, Dacic S, Borczuk AC, et al. Best practices recommendations for diagnostic immunohistochemistry in lung cancer. Thorac Oncol. 2019;14(3):377–407. https://doi.org/10.1016/j.jtho.2018.12.005.

    Article  CAS  Google Scholar 

  7. Jagirdar J. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung. Arch Pathol Lab Med. 2008;132(3):384–96. https://doi.org/10.1043/1543-2165(2008)132[384:AOITTD]2.0.CO;2.

    Article  PubMed  Google Scholar 

  8. Lin F, Chen Z. Standardization of diagnostic immunohistochemistry: literature review and geisinger experience. Arch Pathol Lab Med. 2014;138(12):1564–77. https://doi.org/10.5858/arpa.2014-0074-RA.

    Article  PubMed  Google Scholar 

  9. Rekhtman N, Ang AC, Sima CS, et al. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. 2011;24(10):1348–59. https://doi.org/10.1038/modpathol.2011.92.

  10. Ocque R, Tochigi N, Ohori NP, et al. Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens. Am J Clin Pathol. 2011;136(1):81–7. https://doi.org/10.1309/AJCPFKOLGL6PMOF3.

    Article  PubMed  Google Scholar 

  11. Ishizumi T, McWilliams A, MacAulay C, et al. Natural history of bronchial preinvasive lesions. Cancer Metastasis Rev. 2010;29(1):5–14. https://doi.org/10.1007/s10555-010-9214-7.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Rivera MP. Preinvasive lesions of the bronchus. Clin Chest Med. 2011;32(4):693–702. https://doi.org/10.1016/j.ccm.2011.08.008.

    Article  PubMed  Google Scholar 

  13. Breuer RH, Pasic A, Smit EF, et al. The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res. 2005;11:537–43.

    Article  CAS  PubMed  Google Scholar 

  14. Nguyen C, Larsen NK, Dietz N, et al. Pulmonary atypical adenomatous hyperplasia: diagnostic and therapeutic implications. Cureus. 2019;11(11) https://doi.org/10.7759/cureus.6079.

  15. Lambe G, Durand M, Buckley A, et al. Adenocarcinoma of the lung: from BAC to the future. Insights into Imaging. 2020;19:11(1):69. https://doi.org/10.1186/s13244-020-00875-6.

    Article  Google Scholar 

  16. Kuhn E, Morbini P, Cancellieri A, et al. Adenocarcinoma classification: patterns and prognosis. Pathologica. 2018;110(1):5–11.

    CAS  PubMed  Google Scholar 

  17. Butnor KJ (2020) Controversies and challenges in the histologic subtyping of lung adenocarcinoma. Transl Lung Cancer Res;9(3):839–846. doi: https://doi.org/10.21037/tlcr.2019.12.30.

  18. Weissferdt A, Kalhor N, Moran CA. Well-differentiated adenocarcinoma-bronchioloalveolar carcinoma-in situ adenocarcinoma: a conundrum. Adv Anat Pathol. 2013;20(5):347–51. https://doi.org/10.1097/PAP.0b013e3182a28aa1.

    Article  PubMed  Google Scholar 

  19. Travis WD. Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine. Thorac Surg Clin. 2014;24:257–66.

    Article  PubMed  Google Scholar 

  20. Hutchinson BD, Shroff GS, Truong MT, et al. Spectrum of lung adenocarcinoma. Semin Ultrasound CT MR. 2018;40(3):255–64. https://doi.org/10.1053/j.sult.2018.11.009.

    Article  PubMed  Google Scholar 

  21. Suster S, Cesar AM. Biopsy interpretation of the lung. Philadelphia: Lippincott Williams &Wilkins; 2013.

    Google Scholar 

  22. Travis WD, Brambilla E, Geisinger KR. Histological grading in lung cancer: one system for al lor sperate systems for each histological type. Eur Repir J. 2016;47:720–3.

    Article  Google Scholar 

  23. Zheng M. Classification and pathology of lung cancer. Surg Oncol Clin N Am. 2016;25:447–68.

    Article  PubMed  Google Scholar 

  24. Bonastre E, Brambilla E, Sanchez-Cespedes M. Cell adhesion and polarity in squamous cell carcinoma of the lung. 2016;238(5):606–16. https://doi.org/10.1002/path.4686.

  25. Kadota K, Nitadori J, Woo KM, et al. Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes. Thorac Oncol. 2014;9(8):1126–39. https://doi.org/10.1097/JTO.0000000000000253.

    Article  Google Scholar 

  26. Borczuk AC. Uncommon types of lung carcinoma with mixed histology: Sarcomatoid carcinoma, Adenosquamous carcinoma, and Mucoepidermoid carcinoma. Arch Pathol Lab Med. 2018;142(8):914–21. https://doi.org/10.5858/arpa.2017-0584-RA.

    Article  PubMed  Google Scholar 

  27. Travis WD. Pathology of lung cancer. Clin Chest Med. 2011;32:669–92. https://doi.org/10.1016/j.ccm.2011.08.005.

    Article  PubMed  Google Scholar 

  28. Weissferdt A, Kalhor N, Canales R, et al. Spindle cell and pleomorphic (“sarcomatoid”) carcinomas of the lung: an immunohistochemical analysis of 86 cases. Hum Pathol. 2017;59:1–9. https://doi.org/10.1016/j.humpath.2016.08.003.

    Article  CAS  PubMed  Google Scholar 

  29. Rao N. Adenosquamous carcinoma. Semin Diagn Pathol. 2014;31(4):271–7. https://doi.org/10.1053/j.semdp.2014.06.004.

    Article  PubMed  Google Scholar 

  30. Zhu F, Liu Z, Hou Y, et al. Primary salivary gland-type lung cancer: clinicopathological analysis of 88 cases from China. J Thorac Oncol. 2013;8(12):1578–84. https://doi.org/10.1097/JTO.0b013e3182a7d272.

    Article  PubMed  Google Scholar 

  31. Falk N, Weissferdt A, Kalhor N. Primary pulmonary salivary gland-type tumors: a review and update. Anat Pathol. 2016;23(1):13–23. https://doi.org/10.1097/PAP.0000000000000099.

    Article  CAS  Google Scholar 

  32. Jeffus SK, Gardner JM, Steliga MA, et al. Hyalinizing clear cell carcinoma of the lung: case report and review of the literature. Am J Clin Pathol. 2017;148(1):73–80. https://doi.org/10.1093/ajcp/aqx048.

    Article  PubMed  Google Scholar 

  33. Molina JR, Aubry MC, Lewis JE, et al. Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors. Cancer. 2007;110(10):2253–9. https://doi.org/10.1002/cncr.23048.

    Article  PubMed  Google Scholar 

  34. Hung YP. Neuroendocrine tumors of the lung: updates and diagnostic pitfalls. 2019;12(4):1055–71. https://doi.org/10.1016/j.path.2019.08.012.

  35. Rekhtman N. Neuroendocrine tumors of the lung: an update. Arch Pathol Lab Med. 2010;134(11):1628–38. https://doi.org/10.1043/2009-0583-RAR.1.

    Article  PubMed  Google Scholar 

  36. Naidoo J, Santos-Zabala M, Pietanza MC. Large cell neuroendocrine carcinoma of the lung: clinicopathologic features, treatment, and outcomes. Clin Lung Cancer. 2016;17(5):121–9.

    Article  Google Scholar 

  37. Kalemkerian GP, Loo BW, Akerley W, et al. NCCN guidelines insights: small cell lung cancer. J Natl Comp Canc Netw. 2018;16(10):1171–82. https://doi.org/10.6004/jnccn.2018.0079.

    Article  Google Scholar 

  38. Nicholson SA, Beasley MB, Brambilla E, et al. Small cell lung carcinoma (SCLC): a clinical study of 100 cases with surgical specimens. Am J Surg Pathol. 2002;26:1184–97. https://doi.org/10.1097/00000478-200209000-00009.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Eskisehir Osmangazi University, Medical Faculty Department of Pathology, Eskisehir, Turkey

    Emine Dundar

Authors
  1. Emine Dundar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emine Dundar .

Editor information

Editors and Affiliations

  1. Department of Otorhinolaryngology, Eskişehir Osmangazi University, Eskisehir, Türkiye

    Cemal Cingi

  2. Department of Pulmonology, Celal Bayar University, Manisa, Türkiye

    Arzu Yorgancıoğlu

  3. Department of Otorhinolaryngology, Kırıkkale University, Kırıkkale, Türkiye

    Nuray Bayar Muluk

  4. Federal University of Bahia School of Medicine and ProAR Foundation, Salvador - Bahia, Brazil

    Alvaro A. Cruz

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dundar, E. (2023). Pathology of Lung Cancer. In: Cingi, C., Yorgancıoğlu, A., Bayar Muluk, N., Cruz, A.A. (eds) Airway diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-22483-6_58-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-22483-6_58-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-22482-9

  • Online ISBN: 978-3-031-22483-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation